Literature DB >> 23460713

Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?

Aaron R Hansen, Lillian L Siu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23460713     DOI： 10.1200/JCO.2012.47.9220

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

1.  A bioactivatable self-quenched nanogel for targeted photodynamic therapy.

Authors:  Huacheng He; Anna-Liisa Nieminen; Peisheng Xu
Journal:  Biomater Sci       Date:  2019-10-02       Impact factor: 6.843

2.  Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.

Authors:  Guoqing Qian; Ning Jiang; Dongsheng Wang; Scott Newman; Sungjin Kim; Zhengjia Chen; Gabriela Garcia; Gavin MacBeath; Dong M Shin; Fadlo R Khuri; Zhuo G Chen; Nabil F Saba
Journal:  Cancer       Date:  2015-07-20       Impact factor: 6.860

3.  Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.

Authors:  Traci R Tuttle; Vinita Takiar; Bhavna Kumar; Pawan Kumar; Nira Ben-Jonathan
Journal:  Cancer Lett       Date:  2016-12-23       Impact factor: 8.679

4.  Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection.

Authors:  Hua Li; John S Wawrose; William E Gooding; Levi A Garraway; Vivian Wai Yan Lui; Noah D Peyser; Jennifer R Grandis
Journal:  Mol Cancer Res       Date:  2014-01-14       Impact factor: 5.852

Review 5.  The value of genomics in dissecting the RAS-network and in guiding therapeutics for RAS-driven cancers.

Authors:  Gajendra Shrestha; Shelley M MacNeil; Jasmine A McQuerry; David F Jenkins; Sunil Sharma; Andrea H Bild
Journal:  Semin Cell Dev Biol       Date:  2016-06-20       Impact factor: 7.727

Review 6.  Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance.

Authors:  Nabil F Saba; Zhuo Gerogia Chen; Missak Haigentz; Paolo Bossi; Alessandra Rinaldo; Juan P Rodrigo; Antti A Mäkitie; Robert P Takes; Primoz Strojan; Jan B Vermorken; Alfio Ferlito
Journal:  Mol Cancer Ther       Date:  2019-11       Impact factor: 6.261

7.  Unraveling the molecular genetics of head and neck cancer through genome-wide approaches.

Authors:  Nadeem Riaz; Luc G Morris; William Lee; Timothy A Chan
Journal:  Genes Dis       Date:  2014-09

8.  Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor Growth.

Authors:  Jonathan A Kopechek; Andrew R Carson; Charles F McTiernan; Xucai Chen; Bima Hasjim; Linda Lavery; Malabika Sen; Jennifer R Grandis; Flordeliza S Villanueva
Journal:  Theranostics       Date:  2015-10-16       Impact factor: 11.556

9.  Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis.

Authors:  Matthew M Moldan; Bruce C Bostrom; Robert J Tibesar; Timothy A Lander; James D Sidman
Journal:  F1000Res       Date:  2013-10-03

10.  Effect of nonspecific binding of imaging agents to plasma protein in the paired-agent imaging for resection during surgery (PAIRS).

Authors:  Xiaochun Xu; Kenneth M Tichauer; Kimberley S Samkoe
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2020-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.